Explore more publications!

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on April 6, 2026

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy
ANNA Autism Care Appoints Ariana Boutain, PhD, BCBA-D as Chief Clinical Officer
New LockeT Data Accepted in Leading Electrophysiology Journal
Extendicare Announces Timing of 2026 First Quarter Results and Conference Call
Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
Beacon Biosignals Upsizes Series B Financing to Over $97 Million

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions